Efficacy of micafungin alone or in combination against systemic murine aspergillosis.

Abstract

We tested the efficacy of micafungin (FK) alone or in combination with other antifungals against systemic murine aspergillosis. FK alone at 10 mg/kg of body weight/dose prolonged survival (P = 0.01) and reduced CFU in the brain and kidney. Combination therapy that used suboptimal FK with amphotericin B or itraconazole prolonged survival. Although no survivors were free of infection, no antagonism was seen. Nikkomycin Z with FK showed significantly greater potency (P < 0.01) than either alone.

• Authors: Javier Capilla Luque, Karl V Clemons, David A Stevens
• Journal: Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 47 Issue 4 Pg. 1452-5 (Apr 2003) ISSN: 0066-4804 [Print] United States
• PMID: 12654692 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antifungal Agents
• Echinocandins
• Lipopeptides
• Lipoproteins
• Peptides, Cyclic
• Itraconazole
• Amphotericin B
• Micafungin

Topics

• Amphotericin B (administration & dosage)
• Animals
• Antifungal Agents (therapeutic use)
• Aspergillosis (drug therapy)
• Drug Therapy, Combination
• Echinocandins
• Female
• Itraconazole (administration & dosage)
• Lipopeptides
• Lipoproteins (administration & dosage, therapeutic use)
• Micafungin
• Peptides, Cyclic (administration & dosage, therapeutic use)